STRO Earnings

Quarterly EPS
$-8.55
Q4 2024
$-9.08
Q1 2025
$-1.35
Q2 2025
$-6.66
Q3 2025
$-5.45
Q4 2025
$-2.94
Q1 2026
$-2.33
Q2 2026
$-1.90
Q3 2026
Latest Revenue9.1M
Latest Net Income-31489000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.909.1M-31489000-6.1%+71.5%
Q2 2026-$2.339.8M-38533000-84.6%-72.6%
Q1 2026-$2.9414.5M-38484000-16.5%+67.6%
Q4 2025-$5.4511.6M-46762000-21.4%+36.3%
Q3 2025-$6.669.7M-56857000+13.8%-12.9%
Q2 2025-$1.3563.7M-11499000+148.0%+77.1%
Q1 2025-$9.0817.4M-75968000+33.8%+4.4%
Q4 2024-$8.5514.8M-72443000-87.0%-268.0%
Q3 2024-$5.908.5M-48787000——
Q2 2024-$5.9025.7M-48018000——
Q1 2024-$9.5013.0M-58213000——
Q4 2023$5.09113.7M31.1M——
Sutro Biopharma (STRO) — Earnings